$EVFM 4/A SEC Filings

Filed On	Filing
18 Jun 2020	Form 4/A: Hall William Walmsley, Director Bought 5,000 shares ($14.3K)
03 Dec 2018	Form 4/A: Fitzpatrick Alexander A, General Counsel and Secretary Granted 100,000 Stock option (right to buy)
03 Dec 2018	Form 4/A: File Justin J., Chief Financial Officer Granted 103,500 Stock option (right to buy)
03 Dec 2018	Form 4/A: Pelletier Saundra L, Director Granted 284,625 Stock option (right to buy)
03 Dec 2018	Form 4/A: Barrans Russell, Chief Commercial Officer Granted 100,000 Stock option (right to buy)
03 Dec 2018	Form 4/A: Culwell Kelly, Chief Medical Officer Granted 100,000 Common Stock
17 Aug 2015	Form 4/A: Kemmerer Christopher, VP, Pharma Dev & Manufacturing Received 1,000 shares by exercise or conversion ($1.34K)
10 Dec 2014	Form 4/A: Dp Vii Associates Lp, 10% owner and 6 others Received 46,311 shares by conversion · Received 4,397 shares by exercise or conversion ($37.6K) · Gave up 2,683 shares to cover exercise price or tax ($37.6K)
10 Dec 2014	Form 4/A: Domain Parters Vii L P, 10% owner and 6 others Received 2,921,065 shares by conversion · Received 257,895 shares by exercise or conversion ($2.2M) · Gave up 157,317 shares to cover exercise price or tax ($2.2M) · 1 more
01 Dec 2014	Form 4/A: Janney Daniel, Director and 4 others Received 93,676 shares by exercise ($800K)

Comments